Typical antipsychotic Study guides, Revision notes & Summaries

Final Exam Quizzes: NRNP6635 / NRNP 6635 (Latest 2023 / 2024): Psychopathology and Diagnostic Reasoning - Walden 1. Who is most likely to get medication induced dystonias? ~ Answer: Men and young. treatment IM benadryl, valium 2. Who is most at risk for acute akathisia? (restlessness,) ~ Answer: Middle aged women. Treat by changing drug 3. when does tardive dyskinesia arise Tx? ~ Answer: months to years after a typical antipsychotic med is initiated ~ switch to ...

NRNP 6675-15; NRNP 6675 Week 6 Midterm Exam 2022 100% solved -Graded A+   NRNP 6675-15; NRNP 6675 Week 6 Midterm Exam 2022 100% solved -Graded A+ 1. Which of the following are risk factors for neuroleptic malignant syndrome? Select all that apply Age Rapid dose escalation Parental route of administration Higher potency typical antipsychotics 2. Antipsychotic medications provide D2 blockade in the mesocortical pathway causing which of the following effects? Reduces negative symptoms Increases e...

NR 546 Midterm Exam 2023/2024 Questions AND Answers Update A+ What should the PMHNP consider when prescribing chemical restraints? - Answer-- allergy status -prior med hx for adverse drug reactions r/t the meds ordered in the chemical restraint -state regulations regarding chemical restrains must be reviewed Are the PMHNP and other staff liable if the client has an allergic reaction or adverse side effects to the drugs used for chemical restraint? - Answer-No. The client has been court-...

NCLEX RN NGN EXAM QUESTIONS & ANSWERS 2024 UPDATE NCLEX RN NGN EXAM QUESTIONS & ANSWERS 2024 UPDATE Question 1 Yesterday, a client with schizophrenia began treatment with haloperidol (Haldol). Today, the nurse notices that the client is holding his head to one side and complaining of neck and jaw spasms. What should the nurse do? A Assume that the client is posturing. B Tell the client to lie down and relax. Evaluate the client for adverse reactions to haloperidol. Put the client...

NRNP 6675-15; NRNP 6675 Week 6 Midterm Exam 2022 100% solved -Graded A+   NRNP 6675-15; NRNP 6675 Week 6 Midterm Exam 2022 100% solved -Graded A+ 1. Which of the following are risk factors for neuroleptic malignant syndrome? Select all that apply Age Rapid dose escalation Parental route of administration Higher potency typical antipsychotics 2. Antipsychotic medications provide D2 blockade in the mesocortical pathway causing which of the following effects? Reduces negative symptoms Increases e...

QUESTIONS AND ANSWERS

NRNP 6675-15 Week 6 Midterm Exam 2022 (100% Correct Answers). 1. Which of the following are risk factors for neuroleptic malignant syndrome? Select all that apply Age Rapid dose escalation Parental route of administration Higher potency typical antipsychotics 2. Antipsychotic medications provide D2 blockade in the mesocortical pathway causing which of the following effects? Reduces negative symptoms Increases extra pyramidal symptoms (EPS) Causes prolactinemia Reduces positive sympto...

What nursing intervention is appropriate for a 70-year-old female patient receiving lithium? - Monitor Fluid and Sodium Intake A nurse is caring fora patient who is taking lithium for mania. The nurse’s assessment includes a notation of a lithium serum level of 2.4 mEq/L. The nurse anticipates seeing what? - clonic movements •serum levels of 2-2.5 mEq/L may produce ataxia, clonic movements, possible seizures and hypotension* The nurse administers chlorpromazine intramuscularly...

NRNP 6675-15 Week 6 MIDTERM EXAM 2023/2024 ACTUAL QUESTIONS AND ANSWERS GRADED A+ 1. Which of the following are risk factors for neuroleptic malignant syndrome? Select all that apply  Age  Rapid dose escalation  Parental route of administration  Higher potency typical antipsychotics 2. Antipsychotic medications provide D2 blockade in the mesocortical pathway causing which of the following effects?  Reduces negative symptoms  Increases extra pyramidal symptoms (EP...

Test Bank Stahl’s Essential Psychopharmacology 5th EditionTable of Contents Chapter 1 Chemical neurotransmission ............................................................................................... 1 Chapter 2 Transporters, Receptors, And Enzymes As Targets Of Psychopharmacological Drug Action 8 Chapter 3 Ion Channels as Targets Of Psychopharmacological Drug Action ..................................... 15 Chapter 4 Psychosis and schizophrenia ...........................................